Why You Should Attend?
Step into the future of pharma intelligence at Pharma CI 2026. Connect with senior leaders across pharma, biotech, and medtech while gaining actionable insights from expert-led sessions on the trends shaping the industry. With a highly curated, practitioner-driven audience and research-backed discussions, this is your opportunity to build meaningful connections and drive smarter, faster decisions.
Meet WNS, Part of Capgemini, at the Event
WNS (now part of Capgemini) is at the Pharma CI 2026. Together with Capgemini, we combine deep domain expertise, end-to-end data, analytics and AI capabilities accompanied by scalable delivery capabilities to enable intelligent operations and help pharma organizations move from fragmented insights to faster, sharper decisions driving competitive advantage.
Backed by a global team of domain and AI experts, AI innovation labs and proven experience with 30+ leading life sciences companies. WNS brings a bold, next-gen approach to competitive intelligence—designed to move beyond reporting to real strategic influence. From pipeline tracking and clinical intelligence to market positioning and go-to-market strategy, WNS delivers end-to-end intelligence—integrating primary and secondary research, conference intelligence and advanced analytics to help pharma organizations stay ahead of evolving competition.
Visit our booth to explore how WNS, part of Capgemini, is redefining intelligence—Delivering Sharper Insights and Smarter Decisions.
Speaking Session
Topic: From Competitive Intelligence to Strategic Advantage: How Human-Led, AI-Enabled Intelligence is Redefining Pharma Decision-Making
Speakers
- Letizia Leprini, Global Pharma Strategy - Competitive Intelligence Enabler, Therapeutic Area Oncology-Hematology at F.Hoffmann-La Roche AG
- Dr. Parvin Moyassari, Global Life sciences industry Lead-Insight and Data, Capgemini
- Nancy Grover, CI Expert at WNS
As the pharmaceutical landscape grows more complex, traditional competitive intelligence is no longer enough. Organizations are shifting to Strategic Intelligence—a decision-centric model powered by AI and human expertise.
This session explores how AI-human collaboration is transforming CI into forward-looking, actionable insights that drive sharper insights, smarter decisions and future ready organization. Through real-world examples and best practices. We’ll showcase how organizations are anticipating market shifts, optimizing portfolios and driving competitive advantage.
Meet our experts to exchange insights, explore trends shaping the evolving pharma and competitive intelligence landscape and uncover new ways to drive strategic decisions, optimize portfolios and stay ahead in an increasingly dynamic market.
- Mark Halford, Corporate Vice President, WNS
- Nancy Grover, CI Expert, WNS
- Parvin Moyassari, Global Life sciences industry Lead-Insight and Data at Capgemini
- Abhishek Jain, Vice President, WNS
From fragmented intelligence to competitive edge—powered by scalable AI and deep life sciences expertise, see how leading pharma organizations are turning competitive intelligence into real business impact—from sharper portfolio strategies and faster launch readiness to become industry pioneers. Visit our booth to connect with our experts and discover what’s driving impact today—and what’s next in Strategic Intelligence.
Share your details and choose a time that suits you—we’ll take it from there.